Le Lézard
Classified in: Mining industry, Health, Business
Subject: TNM

CI Capital Partners Completes Sale of Tech Air to Airgas, an Air Liquide Company


NEW YORK, March 19, 2019 /PRNewswire/ -- CI Capital Partners, a New York-based private equity firm, announced today that it has completed the sale of its portfolio company, Tech Air, to Airgas, an Air Liquide (EPA:AI) company. 

(PRNewsfoto/CI Capital Partners)

CI Capital acquired Tech Air, a distributor of industrial, specialty, and medical gases in December 2010 in partnership with its CEO, Myles Dempsey. Under CI Capital's ownership, Tech Air completed 28 add-on acquisitions, expanding the company's geographic reach significantly, from operations in two states to 14 states. Tech Air's revenue increased twelvefold and EBITDA increased eighteenfold. Today, the company serves more than 45,000 customers in its core business of industrial gas distribution and related services.

"This transaction is the culmination of a fruitful partnership with CI Capital whereby Tech Air achieved remarkable growth," said Tech Air CEO Dempsey. "The Tech Air team is proud of our accomplishments and of having Airgas, an industry leader, recognize the value of Tech Air's business."

Joost Thesseling, Managing Director at CI Capital Partners and Chairman of Tech Air, said, "Myles and the team deserve our praise and the recognition received from Airgas for their tireless commitment to becoming a leading packaged gas distributor in the United States. Tech Air is another example of CI Capital executing our buy and build strategy in a distribution business."

Frederick J. Iseman, Chairman and CEO of CI Capital Partners and a Director of Tech Air, said, "Myles and the Tech Air management team were exceptional partners, and we wish them and Airgas continued success."

Harris Williams and Berenson & Company, LLC advised Tech Air on the transaction. Paul, Weiss, Rifkind, Wharton & Garrison LLP provided legal advice.

Exact terms of the transaction have not been made public.

About Tech Air

Founded in 1935, Tech Air is a leading packager and distributor of industrial, medical and specialty gases, welding equipment, and supplies. The company is headquartered in Danbury, Connecticut and operates through 50 branch and fill locations in California, Texas, the Northeast, and the Southeast. Tech Air serves more than 45,000 customers in a wide range of industries. To learn more about Tech Air, please visit www.techair.com.

About CI Capital Partners

CI Capital Partners LLC is a leading North American private equity investment firm that has invested in middle-market companies since 1993. CI Capital forms partnerships with experienced management teams and entrepreneurs to build substantial businesses through add-on acquisitions, organic growth, and operational improvements. Since inception, CI Capital and its portfolio companies have made over 320 acquisitions representing approximately $10 billion in enterprise value. For more information on CI Capital Partners, please visit www.cicapllc.com.

Media Contact:
Daniel Yunger
KEKST
212.521.4800

SOURCE CI Capital Partners


These press releases may also interest you

at 13:26
In a bid to foster excellence and innovation in the healthcare industry, the esteemed Dr. Vidal Sheen proudly announces the launch of The Dr. Vidal Sheen Grant for Healthcare Students. With a robust focus on academic prowess, compassionate care, and...

at 13:17
Rexall is proud to unveil its first Pharmacist Care Walk-In Clinic in Barrie, Ontario on Friday, April 19. Located at 353 Duckworth Street, the clinic will offer personalized care to the community while providing immediate pharmacist treatment for...

at 13:13
Caring for communities extends beyond life-changing work in operating rooms and physician offices. Hartford HealthCare leadership today highlighted its corporate responsibility to environmental, social and economic sustainability in announcing its...

at 13:04
Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch ? Sirolimus drug coated balloon (DCB), for the management of in-stent...

at 12:30
The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best...

at 12:10
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...



News published on and distributed by: